ArticleTherapeutic innovation & regulatory science2022
Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors.
Daniel Tobias Michaeli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it